Venous Thromboembolic Complications in Pediatric Gastrointestinal Diseases: Inflammatory Bowel Disease and Intestinal Failure
In children with gastrointestinal disorders such as inflammatory bowel disease (IBD) and intestinal failure (IF), the risk of venous thromboembolism (VTE) is increased. VTE may lead to pulmonary embolism, sepsis and central line infection, stroke and post-thrombotic syndrome. The purpose of this rev...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-04-01
|
Series: | Frontiers in Pediatrics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fped.2022.885876/full |
_version_ | 1818541358068006912 |
---|---|
author | Renz C. W. Klomberg Lotte E. Vlug Barbara A. E. de Koning Lissy de Ridder |
author_facet | Renz C. W. Klomberg Lotte E. Vlug Barbara A. E. de Koning Lissy de Ridder |
author_sort | Renz C. W. Klomberg |
collection | DOAJ |
description | In children with gastrointestinal disorders such as inflammatory bowel disease (IBD) and intestinal failure (IF), the risk of venous thromboembolism (VTE) is increased. VTE may lead to pulmonary embolism, sepsis and central line infection, stroke and post-thrombotic syndrome. The purpose of this review is to summarize current knowledge and recent advances around VTE management in pediatric gastroenterology with a focus on IBD and IF. The VTE incidence in children with IBD is reported to be around 4–30 per 10,000 patient-years, with higher incidences for hospitalized children. While in general, IF is less common than IBD, the VTE incidence in children with IF is around 750 per 10,000 patient-years. The most common risk factors for development of VTE involve deviations leading to Virchow's triad (endothelial damage, stasis, and hypercoagulability) and include active inflammation, particularly with colonic involvement, presence of a central venous catheter, underlying thrombophilia, reduced mobility, surgery, and hospitalization. Classes of anticoagulants used for treatment of VTE are low molecular weight heparins and vitamin K antagonists. However, the use of direct oral anticoagulants for treatment or prevention of VTE has not been studied in this pediatric population yet. Pediatric gastroenterologists apply different VTE prevention and treatment strategies due to lack of literature and lack of consensus. We discuss the role of primary and secondary prophylactic use of anticoagulants, and provide tools and recommendations for screening, prevention and management for the specific pediatric populations. |
first_indexed | 2024-12-11T22:08:14Z |
format | Article |
id | doaj.art-29b1dcb4b8fa418885223c34d2693230 |
institution | Directory Open Access Journal |
issn | 2296-2360 |
language | English |
last_indexed | 2024-12-11T22:08:14Z |
publishDate | 2022-04-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Pediatrics |
spelling | doaj.art-29b1dcb4b8fa418885223c34d26932302022-12-22T00:48:53ZengFrontiers Media S.A.Frontiers in Pediatrics2296-23602022-04-011010.3389/fped.2022.885876885876Venous Thromboembolic Complications in Pediatric Gastrointestinal Diseases: Inflammatory Bowel Disease and Intestinal FailureRenz C. W. KlombergLotte E. VlugBarbara A. E. de KoningLissy de RidderIn children with gastrointestinal disorders such as inflammatory bowel disease (IBD) and intestinal failure (IF), the risk of venous thromboembolism (VTE) is increased. VTE may lead to pulmonary embolism, sepsis and central line infection, stroke and post-thrombotic syndrome. The purpose of this review is to summarize current knowledge and recent advances around VTE management in pediatric gastroenterology with a focus on IBD and IF. The VTE incidence in children with IBD is reported to be around 4–30 per 10,000 patient-years, with higher incidences for hospitalized children. While in general, IF is less common than IBD, the VTE incidence in children with IF is around 750 per 10,000 patient-years. The most common risk factors for development of VTE involve deviations leading to Virchow's triad (endothelial damage, stasis, and hypercoagulability) and include active inflammation, particularly with colonic involvement, presence of a central venous catheter, underlying thrombophilia, reduced mobility, surgery, and hospitalization. Classes of anticoagulants used for treatment of VTE are low molecular weight heparins and vitamin K antagonists. However, the use of direct oral anticoagulants for treatment or prevention of VTE has not been studied in this pediatric population yet. Pediatric gastroenterologists apply different VTE prevention and treatment strategies due to lack of literature and lack of consensus. We discuss the role of primary and secondary prophylactic use of anticoagulants, and provide tools and recommendations for screening, prevention and management for the specific pediatric populations.https://www.frontiersin.org/articles/10.3389/fped.2022.885876/fullthrombosisCrohn's diseaseulcerative colitisshort bowel syndromethromboprophylaxisanticoagulation |
spellingShingle | Renz C. W. Klomberg Lotte E. Vlug Barbara A. E. de Koning Lissy de Ridder Venous Thromboembolic Complications in Pediatric Gastrointestinal Diseases: Inflammatory Bowel Disease and Intestinal Failure Frontiers in Pediatrics thrombosis Crohn's disease ulcerative colitis short bowel syndrome thromboprophylaxis anticoagulation |
title | Venous Thromboembolic Complications in Pediatric Gastrointestinal Diseases: Inflammatory Bowel Disease and Intestinal Failure |
title_full | Venous Thromboembolic Complications in Pediatric Gastrointestinal Diseases: Inflammatory Bowel Disease and Intestinal Failure |
title_fullStr | Venous Thromboembolic Complications in Pediatric Gastrointestinal Diseases: Inflammatory Bowel Disease and Intestinal Failure |
title_full_unstemmed | Venous Thromboembolic Complications in Pediatric Gastrointestinal Diseases: Inflammatory Bowel Disease and Intestinal Failure |
title_short | Venous Thromboembolic Complications in Pediatric Gastrointestinal Diseases: Inflammatory Bowel Disease and Intestinal Failure |
title_sort | venous thromboembolic complications in pediatric gastrointestinal diseases inflammatory bowel disease and intestinal failure |
topic | thrombosis Crohn's disease ulcerative colitis short bowel syndrome thromboprophylaxis anticoagulation |
url | https://www.frontiersin.org/articles/10.3389/fped.2022.885876/full |
work_keys_str_mv | AT renzcwklomberg venousthromboemboliccomplicationsinpediatricgastrointestinaldiseasesinflammatoryboweldiseaseandintestinalfailure AT lotteevlug venousthromboemboliccomplicationsinpediatricgastrointestinaldiseasesinflammatoryboweldiseaseandintestinalfailure AT barbaraaedekoning venousthromboemboliccomplicationsinpediatricgastrointestinaldiseasesinflammatoryboweldiseaseandintestinalfailure AT lissyderidder venousthromboemboliccomplicationsinpediatricgastrointestinaldiseasesinflammatoryboweldiseaseandintestinalfailure |